A
ANI Pharmaceuticals, Inc. (ANIP)
NGM – Real Time Price. Currency in USD
72.82
-1.32 (-1.78%)
At close: Mar 27, 2026, 4:00 PM EDT
71.37
-1.45 (-1.99%)
After-hours: Mar 27, 2026, 4:59 PM EDT
Get all premium features to the best stock analysis tool
NGM – Real Time Price. Currency in USD
72.82
-1.32 (-1.78%)
At close: Mar 27, 2026, 4:00 PM EDT
71.37
-1.45 (-1.99%)
After-hours: Mar 27, 2026, 4:59 PM EDT
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
| Name | Position |
|---|---|
| Dr. Mary Pao M.D., Ph.D. | Chief Medical Officer |
| Mr. Chad Gassert | Senior Vice President of Corporate Development & Strategy |
| Mr. Christopher K. Mutz | Senior VP & Head of Rare Disease |
| Mr. Muthusamy Shanmugam MS R.Ph. | Head of R&D, COO of New Jersey Operations & Director |
| Mr. Nikhil Lalwani | President, CEO & Director |
| Mr. Ori Gutwerg | Senior Vice President of Generics |
| Mr. Stephen P. Carey | Senior VP of Finance & CFO |
| Date | Type | Document |
|---|---|---|
| 2026-03-03 | 8-K | ani-20260303.htm |
| 2026-01-12 | 8-K | ani-20260112.htm |
| 2025-12-01 | 8-K | ani-20251124.htm |
| 2025-11-10 | 8-K | ani-20251110.htm |
| 2025-11-07 | 10-Q | anip-20250930.htm |
| 2025-09-26 | 8-K | ani-20250926.htm |
| 2025-09-08 | 8-K | ani-20250908.htm |
| 2025-08-08 | 8-K | ani-20250808.htm |
| 2025-07-29 | 8-K | tm2522000d1_8k.htm |
| 2025-07-23 | 8-K | ani-20250723.htm |
| Ms. Elizabeth Powell J.D. |
| Chief Compliance Officer & Head of Legal of Rare Disease |
| Ms. Krista L. Davis | Senior VP & Chief Human Resources Officer |
| Ms. Meredith W. Cook J.D. | Senior VP, General Counsel & Corporate Secretary |